These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2392126)
41. Statistical calculation of detection limits for DNA adducts using the 32P-postlabeling assay with a standard addition procedure. Lutz WK; Lutz U; Gaylor DW Mutat Res; 2002 Jul; 518(2):195-203. PubMed ID: 12113770 [TBL] [Abstract][Full Text] [Related]
42. DNA adduct levels in congenic rapid and slow acetylator mouse strains following chronic administration of 4-aminobiphenyl. Flammang TJ; Couch LH; Levy GN; Weber WW; Wise CK Carcinogenesis; 1992 Oct; 13(10):1887-91. PubMed ID: 1423849 [TBL] [Abstract][Full Text] [Related]
43. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice. Wiseman RW; Miller EC; Miller JA; Liem A Cancer Res; 1987 May; 47(9):2275-83. PubMed ID: 3567921 [TBL] [Abstract][Full Text] [Related]
44. Sex differences in the formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice. Zu HX; Schut HA Carcinogenesis; 1991 Nov; 12(11):2163-8. PubMed ID: 1934305 [TBL] [Abstract][Full Text] [Related]
45. 32P-postlabelling detection of aromatic DNA adducts in peripheral blood lymphocytes from aluminium production plant workers. Schoket B; Phillips DH; Hewer A; Vincze I Mutat Res; 1991 May; 260(1):89-98. PubMed ID: 2027345 [TBL] [Abstract][Full Text] [Related]
46. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Pfau W; Schmeiser HH; Wiessler M Carcinogenesis; 1990 Sep; 11(9):1627-33. PubMed ID: 2401053 [TBL] [Abstract][Full Text] [Related]
47. Detection by 32P-postlabelling of DNA adducts induced by free radicals and unsaturated aldehydes formed during the aerobic decomposition of fecapentaene-12. Povey AC; Wilson VL; Zweier JL; Kuppusamy P; O'Neill IK; Harris CC Carcinogenesis; 1992 Mar; 13(3):395-401. PubMed ID: 1547529 [TBL] [Abstract][Full Text] [Related]
48. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts. Lai CC; Miller EC; Miller JA; Liem A Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742 [TBL] [Abstract][Full Text] [Related]
49. 32P analysis of DNA adducts in tissues of benzene-treated rats. Reddy MV; Blackburn GR; Schreiner CA; Mehlman MA; Mackerer CR Environ Health Perspect; 1989 Jul; 82():253-7. PubMed ID: 2792046 [TBL] [Abstract][Full Text] [Related]
50. Safrole-like DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history. Chen CL; Chi CW; Chang KW; Liu TY Carcinogenesis; 1999 Dec; 20(12):2331-4. PubMed ID: 10590228 [TBL] [Abstract][Full Text] [Related]
51. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020 [TBL] [Abstract][Full Text] [Related]
52. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys. Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355 [TBL] [Abstract][Full Text] [Related]
53. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815 [TBL] [Abstract][Full Text] [Related]
54. Monophosphate 32P-postlabeling assay of DNA adducts from 1,2:3,4-diepoxybutane, the most genotoxic metabolite of 1,3-butadiene: in vitro methodological studies and in vivo dosimetry. Mabon N; Moorthy B; Randerath E; Randerath K Mutat Res; 1996 Nov; 371(1-2):87-104. PubMed ID: 8950354 [TBL] [Abstract][Full Text] [Related]
55. Safrole-DNA adducts in tissues from esophageal cancer patients: clues to areca-related esophageal carcinogenesis. Lee JM; Liu TY; Wu DC; Tang HC; Leh J; Wu MT; Hsu HH; Huang PM; Chen JS; Lee CJ; Lee YC Mutat Res; 2005 Jan; 565(2):121-8. PubMed ID: 15661610 [TBL] [Abstract][Full Text] [Related]
56. Biotransformation and cytotoxic effects of hydroxychavicol, an intermediate of safrole metabolism, in isolated rat hepatocytes. Nakagawa Y; Suzuki T; Nakajima K; Ishii H; Ogata A Chem Biol Interact; 2009 Jun; 180(1):89-97. PubMed ID: 19428348 [TBL] [Abstract][Full Text] [Related]
57. C18 thin-layer chromatographic enhancement of the 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods. Reddy MV J Chromatogr; 1993 May; 614(2):245-51. PubMed ID: 8314936 [TBL] [Abstract][Full Text] [Related]
58. Analysis of the polycyclic aromatic hydrocarbon content of petrol and diesel engine lubricating oils and determination of DNA adducts in topically treated mice by 32P-postlabelling. Carmichael PL; Jacob J; Grimmer G; Phillips DH Carcinogenesis; 1990 Nov; 11(11):2025-32. PubMed ID: 2225336 [TBL] [Abstract][Full Text] [Related]
59. Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats. Waddell WJ; Crooks NH; Carmichael PL Toxicol Sci; 2004 May; 79(1):38-40. PubMed ID: 14976343 [TBL] [Abstract][Full Text] [Related]
60. Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Pfohl-Leszkowicz A; Grosse Y; Kane A; Creppy EE; Dirheimer G Mutat Res; 1993 Oct; 289(2):265-73. PubMed ID: 7690895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]